Try our Advanced Search for more refined results

Teva Asks Supreme Court To Weigh De Novo Review

By Ryan Davis (January 21, 2014, 5:53 PM EST) -- Teva Pharmaceuticals USA Inc. on Thursday asked the U.S. Supreme Court to review a ruling that invalidated some of the patents for its lucrative multiple sclerosis drug Copaxone, arguing the Federal Circuit had failed to give proper deference to the factual findings of district courts....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!